Roswell Park's safe and comfortable BMT unit currently consists of 20 private patient rooms. RPCI has access to the nearly 10 million potential donors in the National Registry, and serves as a regional referral center for harvesting the marrow of donors. For information on the NMDP, visit http://www.marrow-donor.org
On a weekly basis, the RPCI Transplant Service reviews all patients who are considered for BMT and for tissue typing for potential BMT. Patients must fulfill transplant eligibility to ensure optimal patient outcomes. Patients are evaluated and monitored from time of presentation through the entire continuum of care related to BMT, not just the BMT episode.
The RPCI BMT program participates in the Cancer and Leukemia Group B (CALGB) Cooperative Group and has several CALGB trials for BMT open at RPCI.
In addition, the RPCI BMT program also participates as a core member of a consortium for the NCI/NHLBI-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) and at any one time has several open trials. View a listing of open clinical trials at RPCI.